{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:31:50Z","timestamp":1794004310213,"version":"4.8.0"},"reference-count":51,"publisher":"American Chemical Society (ACS)","issue":"7","license":[{"start":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T00:00:00Z","timestamp":1498003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_ccby_termsofuse.html"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001342","name":"Department of Science and Technology, Republic of South Africa","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100001342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004167","name":"Medicines for Malaria Venture","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100004167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007112","name":"University of Cape Town","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100007112","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"Novartis Research Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,18]]},"abstract":"<jats:title>Conspectus<\/jats:title>\n                  <jats:p>New, safe and effective drugs are urgently needed to treat and control malaria and tuberculosis, which affect millions of people annually. However, financial return on investment in the poor settings where these diseases are mostly prevalent is very minimal to support market-driven drug discovery and development. Moreover, the imminent loss of therapeutic lifespan of existing therapies due to evolution and spread of drug resistance further compounds the urgency to identify novel effective drugs. However, the advent of new public\u2013private partnerships focused on tropical diseases and the recent release of large data sets by pharmaceutical companies on antimalarial and antituberculosis compounds derived from phenotypic whole cell high throughput screening have spurred renewed interest and opened new frontiers in malaria and tuberculosis drug discovery.<\/jats:p>\n                  <jats:p>This Account recaps the existing challenges facing antimalarial and antituberculosis drug discovery, including limitations associated with experimental animal models as well as biological complexities intrinsic to the causative pathogens. We enlist various highlights from a body of work within our research group aimed at identifying and characterizing new chemical leads, and navigating these challenges to contribute toward the global drug discovery and development pipeline in malaria and tuberculosis. We describe a catalogue of in-house efforts toward deriving safe and efficacious preclinical drug development candidates via cell-based medicinal chemistry optimization of phenotypic whole-cell medium and high throughput screening hits sourced from various small molecule chemical libraries. We also provide an appraisal of target-based screening, as invoked in our laboratory for mechanistic evaluation of the hits generated, with particular focus on the enzymes within the de novo pyrimidine biosynthetic and hemoglobin degradation pathways, the latter constituting a heme detoxification process and an associated cysteine protease-mediated hydrolysis of hemoglobin. We further expound on the recombinant enzyme assays, heme fractionation experiments, and genomic and chemoproteomic methods that we employed to identify Plasmodium falciparum falcipain 2 (PfFP2), hemozoin formation, phosphatidylinositol 4-kinase (PfPI4K) and Mycobacterium tuberculosis cytochrome bc1 complex as the targets of the antimalarial chalcones, pyrido[1,2-a]benzimidazoles, aminopyridines, and antimycobacterial pyrrolo[3,4-c]pyridine-1,3(2H)-diones, respectively.<\/jats:p>\n                  <jats:p>In conclusion, we argue for the expansion of chemical space through exploitation of privileged natural product scaffolds and diversity-oriented synthesis, as well as the broadening of druggable spaces by exploiting available protein crystal structures, -omics data, and bioinformatics infrastructure to explore hitherto untargeted spaces like lipid metabolism and protein kinases in P. falciparum. Finally, we audit the merits of both target-based and whole-cell phenotypic screening in steering antimalarial and antituberculosis chemical matter toward populating drug discovery pipelines with new lead molecules.<\/jats:p>","DOI":"10.1021\/acs.accounts.6b00631","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T14:44:01Z","timestamp":1498056241000},"page":"1606-1616","source":"Crossref","is-referenced-by-count":30,"title":["Insights into Integrated Lead Generation and Target\nIdentification in Malaria and Tuberculosis Drug Discovery"],"prefix":"10.1021","volume":"50","author":[{"given":"John","family":"Okombo","sequence":"first","affiliation":[{"name":"University of Cape Town , , ,","place":["Rondebosch, South Africa, 7701"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1327-4727","authenticated-orcid":true,"given":"Kelly","family":"Chibale","sequence":"additional","affiliation":[{"name":"University of Cape Town , , ,","place":["Rondebosch, South Africa, 7701"]},{"name":"University of Cape Town , , ,","place":["Rondebosch, South Africa, 7701"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2017,6,21]]},"reference":[{"key":"2026090213045356000_cit1","unstructured":"World Health Organization (WHO).\n          \n          World Malaria Report, 2016; Geneva, Switzerland (accessed Dec 5, 2016)."},{"key":"2026090213045356000_cit2","unstructured":"World Health Organization (WHO).\n          \n          Global Tuberculosis Report 2016; Geneva, Switzerland (accessed Dec 5, 2016)."},{"key":"2026090213045356000_cit3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin\nResistance in Plasmodium falciparum Malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N.\nEngl. J. Med."},{"key":"2026090213045356000_cit4","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMc0805011","article-title":"Evidence\nof Artemisinin-resistant Malaria in western Cambodia","volume":"359","author":"Noedl","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"2026090213045356000_cit5","unstructured":"World Health Organization (WHO).\n          \n          Global Tuberculosis Report 2014; Geneva, Switzerland (accessed Dec 5, 2016)."},{"key":"2026090213045356000_cit6","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nrd1230","article-title":"Virtual Drug Discovery and Development\nfor Neglected\nDiseases Through Public-Private Partnerships","volume":"2","author":"Nwaka","year":"2003","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026090213045356000_cit7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/cmdc.201200428","article-title":"Fueling Open-Source Drug Discovery: 177 Small-molecule\nLeads Against Tuberculosis","volume":"8","author":"Ballell","year":"2013","journal-title":"ChemMedChem"},{"key":"2026090213045356000_cit8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands\nof Chemical Starting Points for Antimalarial\nLead Identification","volume":"465","author":"Gamo","year":"2010","journal-title":"Nature"},{"key":"2026090213045356000_cit9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature09099","article-title":"Chemical Genetics of Plasmodium falciparum","volume":"465","author":"Guiguemde","year":"2010","journal-title":"Nature"},{"key":"2026090213045356000_cit10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nri2017","article-title":"Humanized\nMice in Translational Biomedical\nResearch","volume":"7","author":"Shultz","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"2026090213045356000_cit11","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.drudis.2015.06.009","article-title":"Supporting\nMalaria Elimination with 21st Century Antimalarial Agent Drug Discovery","volume":"20","author":"Diagana","year":"2015","journal-title":"Drug Discovery Today"},{"key":"2026090213045356000_cit12","doi-asserted-by":"publisher","first-page":"7741","DOI":"10.1021\/jm400314m","article-title":"Cell-based\nMedicinal Chemistry Optimization of High-throughput Screening (HTS)\nHits for Orally Active Antimalarials. Part 1: Challenges in Potency\nand Absorption, Distribution, Metabolism, Excretion\/Pharmacokinetics\n(ADME\/PK)","volume":"56","author":"Chatterjee","year":"2013","journal-title":"J. Med. Chem."},{"key":"2026090213045356000_cit13","doi-asserted-by":"publisher","first-page":"7719","DOI":"10.1021\/jm400362b","article-title":"Drug Discovery\nfor Neglected Diseases: Molecular Target-based and Phenotypic Approaches","volume":"56","author":"Gilbert","year":"2013","journal-title":"J. Med. Chem."},{"key":"2026090213045356000_cit14","doi-asserted-by":"publisher","first-page":"7727","DOI":"10.1021\/jm4004279","article-title":"Approaches to Protozoan Drug Discovery: Phenotypic\nScreening","volume":"56","author":"Sykes","year":"2013","journal-title":"J. Med. Chem."},{"key":"2026090213045356000_cit15","doi-asserted-by":"publisher","first-page":"7750","DOI":"10.1021\/jm400279y","article-title":"Cell-based\nMedicinal Chemistry Optimization of High Throughput Screening Hits\nfor Orally Active Antimalarials. Part 2: Hits from SoftFocus Kinase\nand Other Libraries","volume":"56","author":"Younis","year":"2013","journal-title":"J. Med. Chem."},{"key":"2026090213045356000_cit16","doi-asserted-by":"publisher","first-page":"7755","DOI":"10.1021\/jm400381v","article-title":"Development\nof Mycobacterium tuberculosis Whole Cell Screening\nHits as Potential Antituberculosis Agents","volume":"56","author":"Cooper","year":"2013","journal-title":"J.\nMed. Chem."},{"key":"2026090213045356000_cit17","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.4155\/fmc.12.176","article-title":"Antimalarial\nAminothiazoles and Aminopyridines from Phenotypic Whole-cell Screening\nof a SoftFocus Library","volume":"4","author":"Paquet","year":"2012","journal-title":"Future Med. Chem."},{"key":"2026090213045356000_cit18","doi-asserted-by":"publisher","first-page":"7240","DOI":"10.1016\/j.bmc.2015.10.021","article-title":"Aminopyrazolo[1,5-a]pyrimidines as Potential inhibitors\nof Mycobacterium tuberculosis: Structure Activity\nrelationships and ADME Characterization","volume":"23","author":"Soares de Melo","year":"2015","journal-title":"Bioorg.\nMed. Chem."},{"key":"2026090213045356000_cit19","doi-asserted-by":"publisher","first-page":"9371","DOI":"10.1021\/acs.jmedchem.5b01542","article-title":"Pyrrolo[3,4-c]pyridine-1,3(2H)-diones:\nA Novel Antimycobacterial Class Targeting Mycobacterial Respiration","volume":"58","author":"van der Westhuyzen","year":"2015","journal-title":"J. Med. Chem."},{"key":"2026090213045356000_cit20","doi-asserted-by":"publisher","first-page":"7761","DOI":"10.1021\/jm400325j","article-title":"Using Genetic Methods\nto Define The\nTargets of Compounds with Antimalarial Activity","volume":"56","author":"Flannery","year":"2013","journal-title":"J. Med. Chem."},{"key":"2026090213045356000_cit21","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1021\/jm3001373","article-title":"3,5-Diaryl-2-Aminopyridines\nas a Novel Class of Orally Active Antimalarials Demonstrating Single\nDose Cure in Mice and Clinical Candidate Potential","volume":"55","author":"Younis","year":"2012","journal-title":"J. Med. Chem."},{"key":"2026090213045356000_cit22","doi-asserted-by":"publisher","first-page":"9890","DOI":"10.1021\/acs.jmedchem.6b01265","article-title":"Identification of a Potential Antimalarial Drug Candidate\nfrom a Series of 2-Aminopyrazines by Optimization of Aqueous Solubility\nand Potency Across the Parasite Life Cycle","volume":"59","author":"Le Manach","year":"2016","journal-title":"J. Med. Chem."},{"key":"2026090213045356000_cit23","doi-asserted-by":"publisher","first-page":"8839","DOI":"10.1021\/jm500887k","article-title":"Medicinal Chemistry Optimization\nof Antiplasmodial Imidazopyridazine Hits from High Throughput Screening\nof a SoftFocus Kinase Library: Part 2","volume":"57","author":"Le Manach","year":"2014","journal-title":"J. Med.\nChem."},{"key":"2026090213045356000_cit24","doi-asserted-by":"publisher","first-page":"7713","DOI":"10.1021\/jm201108k","article-title":"Novel Orally Active Antimalarial\nThiazoles","volume":"54","author":"Gonzalez Cabrera","year":"2011","journal-title":"J. Med. Chem."},{"key":"2026090213045356000_cit25","doi-asserted-by":"publisher","first-page":"eaad9735","DOI":"10.1126\/scitranslmed.aad9735","article-title":"Antimalarial Efficacy of MMV390048,\nAn Inhibitor of Plasmodium Phosphatidylinositol 4-kinase","volume":"9","author":"Paquet","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"2026090213045356000_cit26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2148-11-4","article-title":"Phylogenomics of Phosphoinositide\nLipid Kinases: Perspectives\non the Evolution of Second Messenger Signaling and Drug Discovery","volume":"11","author":"Brown","year":"2011","journal-title":"BMC Evol. Biol."},{"key":"2026090213045356000_cit27","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.3390\/molecules14082868","article-title":"Recent Advances in the Discovery\nof Haem-Targeting Drugs for Malaria and Schistosomiasis","volume":"14","author":"de Villiers","year":"2009","journal-title":"Molecules"},{"key":"2026090213045356000_cit28","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.jinorgbio.2008.04.001","article-title":"The Crystal Structure\nof Halofantrine-Ferriprotoporphyrin IX and the Mechanism of Action\nof Arylmethanol Antimalarials","volume":"102","author":"de Villiers","year":"2008","journal-title":"J. Inorg. Biochem."},{"key":"2026090213045356000_cit29","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1021\/ml4001084","article-title":"Synthesis, Antiplasmodial Activity,\nand Beta-Hematin\nInhibition of Hydroxypyridone-Chloroquine Hybrids","volume":"4","author":"Andayi","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"2026090213045356000_cit30","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1021\/jm200149e","article-title":"Enone- and\nChalcone-Chloroquinoline Hybrid Analogues: In silico Guided Design,\nSynthesis, Antiplasmodial Activity, In Vitro Metabolism and Mechanistic\nStudies","volume":"54","author":"Guantai","year":"2011","journal-title":"J. Med. Chem."},{"key":"2026090213045356000_cit31","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/cmdc.200800172","article-title":"Reversed Chloroquines\nBased on the 3,4-dihydropyrimidin-2(1H)-one\nScaffold: Synthesis and Evaluation for Antimalarial, Beta-haematin\nInhibition, and Cytotoxic Activity","volume":"3","author":"October","year":"2008","journal-title":"ChemMedChem"},{"key":"2026090213045356000_cit32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1021\/cb300454t","article-title":"Insights Into The\nRole of Heme in the Mechanism of Action of Antimalarials","volume":"8","author":"Combrinck","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"2026090213045356000_cit33","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1021\/acs.jmedchem.6b01641","article-title":"Antimalarial Pyrido[1,2-a]benzimidazoles: Lead Optimization,\nParasite Life Cycle Stage Profile, Mechanistic Evaluation, Killing\nKinetics, and in Vivo Oral Efficacy in a Mouse Model","volume":"60","author":"Singh","year":"2017","journal-title":"J. Med. Chem."},{"key":"2026090213045356000_cit34","doi-asserted-by":"publisher","first-page":"6512","DOI":"10.1021\/acs.jmedchem.6b00719","article-title":"Identification\nand SAR Evaluation of Hemozoin-inhibiting Benzamides Active Against Plasmodium falciparum","volume":"59","author":"Wicht","year":"2016","journal-title":"J. Med. Chem."},{"key":"2026090213045356000_cit35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.micro.51.1.97","article-title":"Hemoglobin Metabolism\nin the Malaria Parasite Plasmodium falciparum","volume":"51","author":"Francis","year":"1997","journal-title":"Annu. Rev. Microbiol."},{"key":"2026090213045356000_cit36","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.1073\/pnas.0307720101","article-title":"Gene Disruption Confirms a Critical\nRole for The Cysteine\nProtease Falcipain-2 in Hemoglobin Hydrolysis by Plasmodium falciparum","volume":"101","author":"Sijwali","year":"2004","journal-title":"Proc. Natl. Acad. Sci.\nU. S. A."},{"key":"2026090213045356000_cit37","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ejmech.2014.11.061","article-title":"Synthesis and Structure-Activity-Relationship\nStudies of Thiazolidinediones as Antiplasmodial Inhibitors of the Plasmodium falciparum Cysteine Protease Falcipain-2","volume":"90","author":"Sharma","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"2026090213045356000_cit38","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.jinorgbio.2010.06.005","article-title":"Synthesis and In Vitro Evaluation\nof Gold(I) Thiosemicarbazone Complexes for Antimalarial Activity","volume":"104","author":"Khanye","year":"2010","journal-title":"J. Inorg. Biochem."},{"key":"2026090213045356000_cit39","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1016\/j.bmc.2005.02.037","article-title":"Design, Synthesis and Anti-plasmodial\nEvaluation In Vitro of New 4-Aminoquinoline Isatin Derivatives","volume":"13","author":"Chiyanzu","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"2026090213045356000_cit40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1023\/A:1006859115450","article-title":"Dihydroorotat-ubiquinone\nOxidoreductase\nLinks Mitochondria in the Biosynthesis of Pyrimidine Nucleotides","volume":"174","author":"Loffler","year":"1997","journal-title":"Mol. Cell. Biochem."},{"key":"2026090213045356000_cit41","doi-asserted-by":"publisher","first-page":"21847","DOI":"10.1074\/jbc.M501100200","article-title":"High-throughput Screening for Potent\nand Selective Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase","volume":"280","author":"Baldwin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2026090213045356000_cit42","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1021\/acs.jcim.5b00680","article-title":"Identification\nof New Human Malaria Parasite Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors\nby Pharmacophore and Structure-Based Virtual Screening","volume":"56","author":"Pavadai","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"2026090213045356000_cit43","doi-asserted-by":"publisher","first-page":"5841","DOI":"10.1021\/jm300157n","article-title":"Factors\nInfluencing the Specificity of Inhibitor Binding to the Human and\nMalaria Parasite Dihydroorotate Dehydrogenases","volume":"55","author":"Bedingfield","year":"2012","journal-title":"J. Med. Chem."},{"key":"2026090213045356000_cit44","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1107\/S2053230X15000989","article-title":"The X-ray Structure\nof Plasmodium falciparum Dihydroorotate Dehydrogenase\nBound to a Potent And Selective N-phenylbenzamide Inhibitor Reveals\nNovel Binding-site Interactions","volume":"71","author":"Deng","year":"2015","journal-title":"Acta Crystallogr.,\nSect. F: Struct. Biol. Commun."},{"key":"2026090213045356000_cit45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for\nBad Bugs: Confronting the Challenges of Antibacterial Discovery","volume":"6","author":"Payne","year":"2007","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026090213045356000_cit46","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nature03194","article-title":"Lessons From Natural Molecules","volume":"432","author":"Clardy","year":"2004","journal-title":"Nature"},{"key":"2026090213045356000_cit47","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/ncomms1081","article-title":"Diversity-oriented Synthesis As a\nTool for the Discovery of Novel Biologically Active Small Molecules","volume":"1","author":"Galloway","year":"2010","journal-title":"Nat. Commun."},{"key":"2026090213045356000_cit48","doi-asserted-by":"publisher","first-page":"D901","DOI":"10.1093\/nar\/gkm958","article-title":"DrugBank:\nA Knowledgebase for Drugs, Drug Actions and Drug Targets","volume":"36","author":"Wishart","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"2026090213045356000_cit49","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1101\/gr.2050304","article-title":"Computational\nAnalysis of Plasmodium falciparum Metabolism: Organizing\nGenomic Information to Facilitate Drug Discovery","volume":"14","author":"Yeh","year":"2004","journal-title":"Genome Res."},{"key":"2026090213045356000_cit50","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bbapap.2005.08.027","article-title":"Protein Kinases as\nTargets for Antimalarial Intervention: Kinomics, Structure-based Design,\nTransmission-blockade, and Targeting Host Cell Enzymes","volume":"1754","author":"Doerig","year":"2005","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"2026090213045356000_cit51","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1021\/cb300151m","article-title":"Identification of Novel Inhibitors\nof M. tuberculosis Growth Using Whole Cell Based\nHigh-Throughput Screening","volume":"7","author":"Stanley","year":"2012","journal-title":"ACS Chem. Biol."}],"container-title":["Accounts of Chemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.accounts.6b00631","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/achre4\/article-pdf\/50\/7\/1606\/66936347\/acs.accounts.6b00631.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/achre4\/article-pdf\/50\/7\/1606\/66936347\/acs.accounts.6b00631.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:05:03Z","timestamp":1788368703000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/achre4\/article\/50\/7\/1606\/1251276\/Insights-into-Integrated-Lead-Generation-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,21]]},"references-count":51,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,6,21]]},"published-print":{"date-parts":[[2017,7,18]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.accounts.6b00631","relation":{},"ISSN":["0001-4842","1520-4898"],"issn-type":[{"value":"0001-4842","type":"print"},{"value":"1520-4898","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,21]]}}}